Anchiano Therapeutics Ltd Gains 187.36%
Wed, Feb 10, 2021 at 05:30 PM
Anchiano Therapeutics Ltd (ANCN:NASDAQ) shot up at $7.96, a gain of 187.4%. The stock got featured on our News Catalysts scanner on Tue 09 Feb 21 at 05:17 PM in the 'MERGER' category. From Tue 26 Jan 21, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Tue 15 Dec 20 at $5.49 with a volume of 92M+.
About Anchiano Therapeutics Ltd (ANCN:NASDAQ)
Anchiano Therapeutics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel therapies to treat cancer in areas of unmet need.
Top 10 Gainers:
- Anchiano Therapeutics Ltd (ANCN:NASDAQ), 187.36%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 126.35%
- United States Antimony Corporation (UAMY:NYSEMKT), 82.56%
- Sundial Growers Inc. (SNDL:NASDAQ), 78.79%
- Tengasco, Inc. (TGC:NYSEMKT), 77.19%
- Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 62.19%
- Tilray, Inc. (TLRY:NASDAQ), 50.91%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 50.53%
- AYRO (AYRO:NASDAQ), 50.2%
- Cancer Genetics, Inc. (CGIX:NASDAQ), 49.05%